Logotype for Docebo Inc

Docebo (DCBO) Q4 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Docebo Inc

Q4 2024 earnings summary

9 Jul, 2026

Executive summary

  • Early impact from three new product modules—AI Authoring, Advanced Analytics, and Communities—has been strong, contributing meaningfully to Q4 results and driving expectations for future growth.

  • Achieved US$220M in Annual Recurring Revenue (ARR) as of December 31, 2024, with 3,978 customers and 900+ employees across global offices.

  • Strategic focus is on transforming from an enterprise LMS to an AI-first learning platform, leveraging GenAI and agentic AI for hyper-personalized, automated, and measurable learning experiences.

  • Leadership changes have brought in experienced talent to support the company’s transformation, while internal succession planning remains a priority.

  • Customer base grew to 3,978, with notable wins including YMCA of the USA, Xponential Fitness, a major European oil & gas company, lululemon, and Databricks.

Financial highlights

  • Q4 2024 total revenue: $57.0M, up 16% year-over-year; subscription revenue: $54.0M, 95% of total.

  • FY2024 total revenue: $216.9M, up 20% year-over-year; subscription revenue: $204.3M, 94% of total.

  • Adjusted EBITDA margin for Q4 2024 was 16.7%, up from 13.2% in Q4 2023; FY2024 Adjusted EBITDA: $33.6M (15.5% margin), up from $16.3M (9.0%).

  • Free cash flow for FY2024: $32.3M (15% of revenue), up from $20.1M (11%).

  • Net income for FY2024: $26.7M ($0.88/share), up from $2.8M ($0.09/share) prior year.

Outlook and guidance

  • FY2025 subscription revenue growth expected at 11.5–12.5% (or 13.0–14.0% adjusted for FX); total revenue growth 11.0–12.0% (or 12.5–13.5% adjusted for FX).

  • Expectation to reach FedRAMP ATO status by end of Q3 2025, enabling pursuit of U.S. federal contracts; current guidance does not include material federal contract revenue.

  • FY2025 Adjusted EBITDA margin guidance: 18.0–19.0%.

  • Ongoing investment in R&D (16-18% of revenue) and sales/marketing (28-32% of revenue) to drive innovation and market penetration.

  • Q1 2025 revenue guidance: $57.0–$57.2M, with Adjusted EBITDA margin 14.5–15.0%.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more